Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kezar Life Sciences, Inc. Director's Dealing 2020

Feb 6, 2020

34845_dirs_2020-02-06_dd9c5500-f519-4b1a-b7ae-bf513d8e1578.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2020-02-04

Reporting Person: Morningside Venture Investments Ltd (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-04 Common Stock P 3800000 $2.60 Acquired 6109052 Direct

Footnotes

F1: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.